FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to phthisiology, and can be used for diagnosing tuberculosis in patients with limited opacification in lungs. Anamnesis is collected, including age, phthisiology group, fact of alcohol consumption, presence of contact with patient with tuberculosis, presence of oncological disease, presence of focal formations detected by radiation method of examination. Peripheral venous blood is sampled, and the level of stab neutrophils and lymphocytes in the blood sample is determined. Thereafter, the patient is identified as belonging to a group of patients with tuberculosis (R) by a given formula. If the R value is less than or equal to 0, the presence of tuberculosis is diagnosed in the patient with limited pulmonary opacification, and if R is more than 0, the absence of tuberculosis is diagnosed in the patient with limited pulmonary opacification.
EFFECT: method enables diagnosing tuberculosis with limited pulmonary opacification without detecting bacterial excretion by evaluating a combination of the most significant values.
1 cl, 1 dwg, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING RISK OF DEVELOPING CENTRAL NERVOUS SYSTEM TUBERCULOSIS IN PATIENTS SUFFERING HIV-ASSOCIATED RESPIRATORY TUBERCULOSIS | 2011 |
|
RU2487355C1 |
METHOD FOR DIAGNOSIS OF ALLERGIC PLEURISY | 0 |
|
SU1639637A1 |
METHOD OF DETERMINING ACTIVITY OF FEMALE GENITAL TUBERCULOSIS | 2011 |
|
RU2470305C1 |
METHOD FOR TUBERCULOUS RHEUMATISM ACTIVITY TEST | 2011 |
|
RU2473085C1 |
METHOD OF DETERMINING ACTIVITY OF SPECIFIC INFLAMMATION WITH MINIMUM TUBERCULOSIS CHANGES IN CHILDREN AND ADOLESCENTS | 2019 |
|
RU2728943C1 |
METHOD FOR PREDICTION OF PULMONARY TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2012 |
|
RU2504787C1 |
METHOD FOR TREATMENT OF CASEOUS PNEUMONIA | 2002 |
|
RU2224511C1 |
METHOD OF TREATING PATIENTS WITH TUBERCULOUS EXUDATIVE PLEURITIS | 2012 |
|
RU2491089C1 |
METHOD FOR DETERMINING THE LIKELIHOOD OF TUBERCULOSIS AS OPPOSED TO PNEUMONIA BY EIGHT INDICATORS OF A GENERAL BLOOD TEST | 2020 |
|
RU2746527C1 |
METHOD FOR EVALUATING CLINICAL EFFECTIVENESS AND DYNAMICS OF DESTRUCTIVE CHANGES IN PULMONARY TISSUE ACCOMPANYING PULMONARY TUBERCULOSIS | 2010 |
|
RU2447445C1 |
Authors
Dates
2024-02-28—Published
2023-05-10—Filed